Make Better Informed Decisions With A Proven Technology for Microbial Strain Selection

Making confident early decisions in microbial development can significantly reduce downstream risk and timelines. A data‑driven strain selection strategy combines platform technologies, high‑throughput screening, and deep microbial expertise to identify high‑performing candidates faster and with greater certainty.

Antibiotic‑free expression systems, innovative vectors, and selected host cells enable rapid evaluation based on both titer and quality, supporting earlier alignment with GMP requirements. Industry‑leading titers and established fermentation methods help teams move efficiently from gene to clinic while maintaining flexibility for diverse recombinant proteins. Integrated purification approaches further streamline development by reducing downstream complexity and accelerating the transition from process development to GMP manufacturing.

Backed by decades of microbial bioprocessing experience and thousands of strains and batches, this approach supports better‑informed decisions when timelines, scalability, and product quality matter most. Read the full brochure to see how smarter strain selection can de‑risk programs from the start.